Insider · CIK 0001569706

Averback Paul

Reports to the SEC for 1 company · ST. LAURENT, A8

Transactions

Companies

Filings

CIK

0001569706

Forms 4 and 5

Insider transactions

2 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-10-29	NYMXFNYMOX PHARMACEUTICAL CORPS Sale	Director, CEO, 10% Owner	SSale	−1.69M sh	$2.50	−$4.22M	21,643,948
2018-10-26	NYMXFNYMOX PHARMACEUTICAL CORPS Sale	Director, CEO, 10% Owner	SSale	−100K sh	$1.75	−$175K	23,331,448

C/O NYMOX PHARMACEUTICAL CORPORATION 9900 CAVENDISH BLVD., SUITE 306

ST. LAURENT, A8, H4M 2V2